Last updateTue, 05 Dec 2023 9am

Back You are here: Inicio Biology & biomedicine

Multiplexed 'point-of-care' device for a quick simultaneous detection of biomarkers

CSIC scientists have developed a compact device for a rapid and simultaneous detection of several biomarkers in biological fluids. The design simplifies scalability and reduces production costs, which is especially important for the obtention of ‘point-of-care’ diagnostic devices. Industrial partners from the biomedical industry are being sought to collaborate through a patent licence agreement.

Read more ...

IBMB-CSIC acquires a state-of-the-art electronic microscope with the most advanced electrons detector

The microscope has been acquired by means of a cooperative project headed by CSIC, through IBMB, and has been co-financed by European FEDER funds. It is a cutting-edge technology for protein structure resolution, and it will allow facing the new biomedicine and biotechnology challenges.

Read more ...

SINGEK trains a new generation of Single Cell Genomics experts

The SINGEK project is now finished. It was a project coordinated by the Institut de Ciències del Mar (ICM, by its Spanish acronym) of the CSIC, and it had as a main goal the training of young researchers in the application of single cell genomics for the study of microbial eukaryotes’ ecology and evolution. This emerging methodology also has applications in biotechnology and biomedicine.

Read more ...

A more effective nanomedicine has been developed for the treatment of Fabry rare disease

This is one of the major achievements of the European Smart4Fabry project, which is now coming to an end after four years of work. The results have been made possible by nanotechnology and the approach developed could be applied to other drugs in the future. The new drug improves on current treatments and helps reduce costs and improve patients' quality of life.

Read more ...

A laboratory at the IQAC-CSIC obtains the biosafety level 2 accreditation

The Institute of Advanced Chemistry of Catalonia (IQAC-CSIC) has obtained the biosafety level 2 accreditation for one of its laboratories, which allows the laboratory to work with biological agents classified in the risk group 2.

Read more ...